Sentinel lymphadenectomy for breast cancer in a community managed care setting

Cancer Journal from Scientific American

Volumn 3, Issue 6, 1997, Pages 336-340

  Guenther, J Michael ^a   Krishnamoorthy, Mohan ^a   Tan, Larissa R ^a  

^a KAISER PERMANENTE MEDICAL CENTER   (United States)

Author keywords

Axilla; Breast neoplasms; Diagnosis; Lymphatic system; Pathology; Surgery

Indexed keywords

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER STAGING; CLINICAL TRIAL; COMMUNITY CARE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MANAGED CARE; MASTECTOMY; PARTIAL MASTECTOMY; PRIORITY JOURNAL; PROSPECTIVE STUDY; VITAL STAIN;

ADULT; AGED; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; INTRAOPERATIVE CARE; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MANAGED CARE PROGRAMS; MIDDLE AGED; NEOPLASM STAGING; PROSPECTIVE STUDIES;

EID: 0031440406     PISSN: 10814442     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Fisher B, Wolmark N, Bauer M et al. The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast. Surg Gynecol Obstet 1981;152:765-772.
2. Musumeci R, Tess T, Costa A et al. Indirect lymphangiography of the breast with Iotasul: a vanishing hope? Lymphology 1984;17: 118-123.
3. Nieweg O, Kim E, Wong W et al. Positron emission with fluorine-18-deoxyglucose in the detection and staging of breast cancer. Cancer 1993;71:3920-3925.
4. Kinne D. Controversies in primary breast cancer management. Am J Surg 1993;166:502-508.
5. Moffat F, Semofsky G, Davis K et al. Axillary node dissection for early breast cancer: some is good, but all is better. J Surg Oncol 1992;51:8-13.
6. Sacre R. Clinical evaluation of axillary lymph nodes to surgical and pathological findings. Eur J Surg Oncol 1986;12:169-173.
7. Shaw J, Rumball E. Controversies in primary breast cancer management. Am J Surg 1993;166:502-508.
8. Morton DL, Wen D, Cochran A. Management of early-stage melanoma by intraoperative lymphatic mapping and selective lymphadenectomy: an alternate to routine elective lymphadenectomy or "watch and wait." Surgical Oncology Clinics of North America 1992;1:247-249.
9. Morton DL, Wen D-R, Wong J et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392-399.
10. Giuliano AE, Kirgan DM, Guenther JM et al. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220:391-401.
11. Giuliano AE, Dale PS, Turner RR et al. Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 1995; 222:394-401.
12. Albertini JJ, Lyman OH, Cox C et al. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. JAMA 1996;276: 1818-1822.
13. Cox C, Reintgen D. In reply [letter]. JAMA 1997;277:791-792.
14. Huvos AG, Rutter RVP, Berg JW. Significance of axillary macrometastases and micrometastases in mammary cancer. Ann Surg 1971;173:44-46.
15. Fisher ER, Swamidoss S, Lee CH et al. Detection and significance of occult axillary node metastases in patients with invasive breast cancer. Cancer 1978;45:2025-2031.
16. Friedman S, Bertin H, Mouriesse H et al. Importance of tumor cells in axillary node sinus margins ("clandestine" metastases) discovered by serial sectioning in operable breast carcinoma. Acta Oncol 1988;27:483-487.
17. Wilkinson EJ, Hause LL, Hoffman RG et al. Occult axillary lymph node metastases in invasive breast carcinoma: characteristics of the primary tumor and significance of the metastases. Pathol Annu 1982;17:67-91.
18. International (Ludwig) Breast Cancer Study Group. Prognostic importance of occult axillary lymph node micrometastases from breast cancers. Lancet 1990;335:1565-1568.
19. McCarthy WH, Thompson JF, Uren RF. Invited commentary. Arch Surg 1995;130:659-660.
20. Giuliano AE. Lymphatic mapping and sentinel node biopsy in breast cancer [letter]. JAMA 1997;277:791.